Zoetis Inc. (ZTS)

Basic

  • Market Cap

    $87.37B

  • EV

    $92.16B

  • Shares Out

    457.87M

  • Revenue

    $8,544M

  • Employees

    14,100

Margins

  • Gross

    70.06%

  • EBITDA

    40.82%

  • Operating

    35.96%

  • Pre-Tax

    34.36%

  • Net

    27.43%

  • FCF

    18.97%

Returns (5Yr Avg)

  • ROA

    12.37%

  • ROTA

    129.23%

  • ROE

    51.6%

  • ROCE

    23.48%

  • ROIC

    23.5%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $221.93

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $2,041M

  • Net Debt

    $4,797M

  • Debt/Equity

    1.37

  • EBIT/Interest

    12.85

Growth (CAGR)

  • Rev 3Yr

    8.58%

  • Rev 5Yr

    7.96%

  • Rev 10Yr

    6.48%

  • Dil EPS 3Yr

    14.02%

  • Dil EPS 5Yr

    11.59%

  • Dil EPS 10Yr

    17.53%

  • Rev Fwd 2Yr

    7.42%

  • EBITDA Fwd 2Yr

    8.04%

  • EPS Fwd 2Yr

    10.63%

  • EPS LT Growth Est

    10.2%

Dividends

  • Yield

  • Payout

    29.51%

  • DPS

    $1.5

  • DPS Growth 3Yr

    23.31%

  • DPS Growth 5Yr

    24.37%

  • DPS Growth 10Yr

    22.63%

  • DPS Growth Fwd 2Yr

    11.81%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Total Revenues

6,260

6,675

7,776

8,080

8,544

Total Revenues % Chg.

7.5%

6.6%

16.5%

3.9%

5.7%

Cost of Goods Sold, Total

1,915

2,038

2,295

2,446

2,558

Gross Profit

4,345

4,637

5,481

5,634

5,986

Selling General & Admin Expenses, Total

1,636

1,713

2,001

2,009

2,151

R&D Expenses

457

463

508

539

614

Amortization of Goodwill and Intangible Assets

155

160

161

150

149

Other Operating Expenses, Total

2,248

2,336

2,670

2,698

2,914

Operating Income

2,097

2,301

2,811

2,936

3,072

Interest Expense, Total

-223

-231

-224

-221

-239

Interest And Investment Income

37

12

6

50

105

Net Interest Expenses

-186

-219

-218

-171

-134

Income (Loss) On Equity Invest.

Currency Exchange Gains (Loss)

-16

-21

-27

-62

-47

Other Non Operating Income (Expenses)

16

7

6

18

36

EBT, Excl. Unusual Items

1,911

2,068

2,572

2,721

2,927

Restructuring Charges

-38

-40

-45

-15

-55

Merger & Related Restructuring Charges

Gain (Loss) On Sale Of Investments

-4

Gain (Loss) On Sale Of Assets

19

-3

101

Asset Writedown

-30

-30

-46

-36

Insurance Settlements

Legal Settlements

Other Unusual Items

-72

-17

-6

-4

-1

EBT, Incl. Unusual Items

1,801

1,996

2,488

2,656

2,936

Income Tax Expense

301

360

454

545

596

Earnings From Continuing Operations

1,500

1,636

2,034

2,111

2,340

Minority Interest

2

3

3

4

Net Income

1,500

1,638

2,037

2,114

2,344

Net Income to Common Incl Extra Items

1,500

1,638

2,037

2,114

2,344

Net Income to Common Excl. Extra Items

1,500

1,638

2,037

2,114

2,344

Total Shares Outstanding

475.5

475.3

472.6

463.8

458.4

Weighted Avg. Shares Outstanding

478.1

475.5

474.3

468.9

461.2

Weighted Avg. Shares Outstanding Dil

481.8

478.6

476.7

470.4

462.3

EPS

3.1

3.4

4.3

4.5

5.1

EPS Diluted

3.1

3.4

4.3

4.5

5.1

EBITDA

2,482

2,696

3,207

3,332

3,488